Transforming drug development by rapidly and quantitatively measuring the affinities of millions of protein-protein interactions - we're hiring!
Joined April 2018
- Tweets 112
- Following 262
- Followers 894
- Likes 207
27 Photos and videos
13 Nov 2024
Check out our new AlphaBind preprint demonstrating our industry-leading antibody optimization model!
Also excited to share that we have measured our BILLIONTH protein-protein interaction, providing the crucial training data to predict protein binding.
biorxiv.org/content/10.1101/…
11
75
6,725
A-Alpha Bio retweeted
7 Dec 2023
Excited to share our new paper using AlphaSeq data to enable predictive ML models for antibody engineering with our wonderful collaborators at @Google and @LumenBio
biorxiv.org/content/10.1101/…
4
18
1,561
A-Alpha Bio retweeted
2 Dec 2023
Excited to announce our latest paper on ML-guided design of single-domain antibodies against CoV-2; A collaboration between @GoogleDeepMind, @AAlphaBio and @LumenBio.
1
14
95
9,514
A-Alpha Bio retweeted
11 Jan 2023
Don't miss our first Founded & Funded of the year! @CPicardo talks w/ @AAlphabio's @DavidAYounger about #ML in #biotech, building business models around data, and when the CEO shouldn't be in the room! Full episode 👉 bit.ly/3IpfxGt What advice do you have for founders?
1
2
10
1,030
A-Alpha Bio retweeted
5 Jan 2023
It was a pleasure speaking with @CPicardo from @MadronaVentures about @AAlphaBio and building a company at the intersection of life science and data science. Thank you for featuring A-Alpha Bio in the first Founded and Funded podcast of 2023!
5 Jan 2023
This week on Founded & Funded, @CPicardo is talking with @DavidAYounger from @AAlphaBio — the first biotech company to make the #IA40. They dive into #ML in #biotech, building cross-functional teams & having both tech and biotech-focused investors. 👂 👉 bit.ly/3IpfxGt
3
11
1,491
A-Alpha Bio retweeted
15 Dec 2022
Applied machine/deep learning & #lifesciences are coming together to transform how we understand & improve life/health. We want to partner w/ teams focused on building wet/dry lab platforms & novel datasets to disrupt traditional drug discovery processes. bit.ly/3FTANT5
4
5
26 Oct 2022
We’re thrilled to be part of the Top 40 Intelligent Applications created by @MadronaVentures, @PitchBook, and @GoldmanSachs. We'll celebrate next week at the #IA40 Summit sponsored by @Microsoft @Amazon.
1
9
24 Aug 2022
Thank you to @frankvinluan at @medcitynews for featuring our latest collaboration with @bmsnews!
bit.ly/3wsP6Zz
#drugdiscovery #biotech #biopharma #proteindegradation
2
5
23 Aug 2022
We are excited to announce our collaboration with Bristol Myers Squibb (@bmsnews) to discover molecular glue targets for protein degradation. Read more here: prweb.com/releases/a_alpha_b…
2
12
A-Alpha Bio retweeted
31 Mar 2022
A special thank you to our alumni sponsors who participated in previous Genome Startup Day discussions & continue to support our events. We appreciate your contributions to making this an impactful and collaborative community.
@TwinStrandBio, @AAlphaBio, @WatchmakerGeno @seqWell
1
4
9
29 Mar 2022
A-Alpha Bio has been selected as a finalist for the annual @geekwire Awards Health Innovation of the Year! It's a fantastic honor to be recognized as a finalist and a testament to the incredible science A-Alpha Bio is doing and our company's progress.
geekwire.com/2022/announcing…
3
9
1 Mar 2022
We are very excited to announce our collaboration with @Livermore_Lab to accelerate antibody discovery for emerging COVID-19 variants by training machine learning models with binding data from AlphaSeq.
Read more below!
prweb.com/releases/a_alpha_b…
2
10
A-Alpha Bio retweeted
15 Feb 2022
We are thrilled to share we've raised $41.5M in our Series B that will grow our team and expand our product portfolio! Thanks to Marshall Wace and @JHIAdvisors for co-leading the round. Check out the release for even more details hubs.la/Q0149Y620 #singlecell #tech #vc
8
44
27 Jan 2022
As we prepare for a virtual company-wide retreat tomorrow, we can't help but reminisce on previous in-person team events and how much fun they were...looking forward to the return of more moments like these soon!
4
22 Dec 2021
"The partnership is the first announced by A-Alpha Bio in the cutting-edge and rapidly growing area of targeted protein degradation and leverages the AlphaSeq platform to quantitatively measure protein-protein binding..."
Read more below in case you missed our exciting news!
20 Dec 2021
.@AAlphaBio Partners with @KymeraTx to Discover Novel Interactions for Molecular Glue Discovery ow.ly/2NzG50HeJBX
4
A-Alpha Bio retweeted
16 Dec 2021
@KymeraTx is thrilled to partner with @AAlphaBio to discover and characterize novel pairs of E3 ubiquitin ligases and high-value therapeutic targets for the rational and prospective design and development of molecular glues.
16 Dec 2021
We're delighted to share that we have partnered with @KymeraTx to take on the field of targeted protein degradation! Using our AlphaSeq assay, we'll identify novel interactions between high value undruggable targets and a library of E3 ubiquitin ligases to discover mol glues(1/3)
1
1
7
16 Dec 2021
We're delighted to share that we have partnered with @KymeraTx to take on the field of targeted protein degradation! Using our AlphaSeq assay, we'll identify novel interactions between high value undruggable targets and a library of E3 ubiquitin ligases to discover mol glues(1/3)
1
6
52
16 Dec 2021
We are very excited for this first-of-its-kind program, and we couldn’t ask for a better partner in Kymera, with their track record of innovation and deep expertise in targeted protein degradation. Follow the link below to learn more about this partnership! (2/3)
1
3
30 Nov 2021
We are thrilled to announce that Padma Kodukula has joined A-Alpha Bio as Chief Business Officer! Padma will play the invaluable role of overseeing our BD strategy, with a focus on establishing and expanding key drug discovery partnerships.
Read more:
prweb.com/releases/padma_kod…
3